Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

TORRENT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 29.8926.6019.6619.3818.62

What is the latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS is 29.89 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202529.89
Mar202426.60
Mar202319.66
Mar202219.38
Mar202118.62

How is EV/Core EBITDA of TORRENT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 29.89
12.37
Mar2024 26.6
35.30
Mar2023 19.66
1.44
Mar2022 19.38
4.08
Mar2021 18.62 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹144,375.0 Cr -0% -3% 33.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics
MANKIND PHARMA ₹84,227.3 Cr 2% -0.6% -16.4% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-0%

-3%

33.3%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses